$SRRK
Scholar Rock Holding Corp

2023 Q1 Form 10-K Financial Statement

#000155837023002992 Filed on March 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $33.19M
YoY Change -100.0% -100.0% 76.41%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.77M $10.82M $43.12M
YoY Change -63.31% 4.37% 7.08%
% of Gross Profit
Research & Development $29.74M $29.61M $124.4M
YoY Change 1.26% 1.93% 14.73%
% of Gross Profit
Depreciation & Amortization $733.0K $749.0K $2.986M
YoY Change -2.14% 3.03% 13.67%
% of Gross Profit
Operating Expenses $40.51M $40.43M $167.6M
YoY Change 0.95% 2.58% 12.66%
Operating Profit -$40.51M -$134.4M
YoY Change 484.29% 3.42%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.130M $1.173M -$132.0K
YoY Change -211.11% -313.27% -92.97%
Pretax Income -$39.38M -$39.26M -$134.5M
YoY Change 395.33% 9.3% 2.05%
Income Tax
% Of Pretax Income
Net Earnings -$39.38M -$39.26M -$134.5M
YoY Change 395.33% 9.3% 2.05%
Net Earnings / Revenue -405.21%
Basic Earnings Per Share -$0.49 -$2.26
Diluted Earnings Per Share -$0.49 -$0.49 -$2.26
COMMON SHARES
Basic Shares Outstanding 51.99M 51.66M 59.61M
Diluted Shares Outstanding 79.61M 59.61M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $275.3M $315.4M $315.4M
YoY Change 30.96% 24.65% 24.65%
Cash & Equivalents $151.3M $103.3M $103.3M
Short-Term Investments $124.0M $212.1M $212.1M
Other Short-Term Assets $11.87M $12.66M $12.66M
YoY Change -35.38% 2.74% 2.74%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $287.2M $328.0M $328.0M
YoY Change 25.62% 23.63% 23.63%
LONG-TERM ASSETS
Property, Plant & Equipment $6.681M $7.384M $25.93M
YoY Change -29.36% -22.79% -25.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.653M $1.719M $4.217M
YoY Change -0.9% 5.98% 2.35%
Total Long-Term Assets $27.56M $30.14M $30.14M
YoY Change -26.28% -22.96% -22.96%
TOTAL ASSETS
Total Short-Term Assets $287.2M $328.0M $328.0M
Total Long-Term Assets $27.56M $30.14M $30.14M
Total Assets $314.7M $358.2M $358.2M
YoY Change 18.33% 17.65% 17.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.720M $3.994M $3.994M
YoY Change 24.29% -9.92% -9.92%
Accrued Expenses $14.73M $24.32M $32.17M
YoY Change -7.58% 39.33% 29.4%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $26.21M $36.39M $36.39M
YoY Change -21.47% -43.4% -43.4%
LONG-TERM LIABILITIES
Long-Term Debt $49.83M $49.74M $49.74M
YoY Change 14.23% 2.73% 2.73%
Other Long-Term Liabilities $10.03M $11.80M $11.80M
YoY Change -43.23% -39.96% -39.96%
Total Long-Term Liabilities $49.83M $49.74M $61.54M
YoY Change 14.23% 2.73% -9.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.21M $36.39M $36.39M
Total Long-Term Liabilities $49.83M $49.74M $61.54M
Total Liabilities $86.07M $97.93M $97.93M
YoY Change -9.08% -26.02% -26.02%
SHAREHOLDERS EQUITY
Retained Earnings -$550.0M -$510.6M
YoY Change 43.2% 35.76%
Common Stock $52.00K $52.00K
YoY Change 48.57% 48.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $228.7M $260.2M $260.2M
YoY Change
Total Liabilities & Shareholders Equity $314.7M $358.2M $358.2M
YoY Change 18.33% 17.65% 17.65%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$39.38M -$39.26M -$134.5M
YoY Change 395.33% 9.3% 2.05%
Depreciation, Depletion And Amortization $733.0K $749.0K $2.986M
YoY Change -2.14% 3.03% 13.67%
Cash From Operating Activities -$43.05M -$28.91M -$132.7M
YoY Change 1.15% -10.93% 4.66%
INVESTING ACTIVITIES
Capital Expenditures $30.00K $117.0K $1.064M
YoY Change -93.23% -121.59% -79.73%
Acquisitions
YoY Change
Other Investing Activities $90.01M $194.0K -$170.6M
YoY Change -228.35% -99.35% -222.26%
Cash From Investing Activities $89.98M $77.00K -$171.7M
YoY Change -227.5% -99.74% -227.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $195.3M
YoY Change 1391.52%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.076M -970.0K 194.8M
YoY Change 123.7% -102.44% 333.43%
NET CHANGE
Cash From Operating Activities -43.05M -28.91M -132.7M
Cash From Investing Activities 89.98M 77.00K -171.7M
Cash From Financing Activities 1.076M -970.0K 194.8M
Net Change In Cash 48.01M -29.80M -109.6M
YoY Change -142.61% -181.19% -308.78%
FREE CASH FLOW
Cash From Operating Activities -$43.05M -$28.91M -$132.7M
Capital Expenditures $30.00K $117.0K $1.064M
Free Cash Flow -$43.08M -$29.02M -$133.8M
YoY Change 0.18% -9.05% 1.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001727196
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35209099
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51672579
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-38501
CY2022 dei Entity Registrant Name
EntityRegistrantName
SCHOLAR ROCK HOLDING CORP
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-3750435
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
301 Binney Street, 3rd Floor
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02142
CY2022 dei City Area Code
CityAreaCode
857
CY2022 dei Local Phone Number
LocalPhoneNumber
259-3860
CY2022 dei Security12b Title
Security12bTitle
Common Stock
CY2022 dei Trading Symbol
TradingSymbol
SRRK
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
109500000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51985072
CY2022 dei Auditor Firm
AuditorFirmId
42
CY2022 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2022 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103275000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
212835000
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
212086000
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
40159000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12663000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12325000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
328024000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
265319000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7384000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9564000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18543000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25442000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2498000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2498000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1719000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1622000
CY2022Q4 us-gaap Assets
Assets
358168000
CY2021Q4 us-gaap Assets
Assets
304445000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3994000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4434000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24321000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17456000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7852000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7407000
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1577000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
33193000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
222000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
230000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11800000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19652000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36389000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
64297000
CY2021Q4 us-gaap Liabilities
Liabilities
132371000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
49744000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
48422000
CY2022Q4 us-gaap Liabilities
Liabilities
97933000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6892000
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-20000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51672579
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35209099
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
52000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
35000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
771699000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
548204000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-884000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-35000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-510632000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-376130000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
260235000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
172074000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
358168000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
304445000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33193000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18816000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
124444000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
108468000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43119000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40269000
CY2022 us-gaap Operating Expenses
OperatingExpenses
167563000
CY2021 us-gaap Operating Expenses
OperatingExpenses
148737000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-134370000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-129921000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-132000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1878000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-134502000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-131799000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.26
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.59
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59611656
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36711833
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-134502000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-131799000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-849000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-33000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-849000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-33000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-135351000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13095000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-131832000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
260770000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-33000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13095000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6892000
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
23149000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-131799000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
172074000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-849000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
195315000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
496000
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
27701000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-134502000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
260235000
CY2022 us-gaap Profit Loss
ProfitLoss
-134502000
CY2021 us-gaap Profit Loss
ProfitLoss
-131799000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2986000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2627000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
720000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
335000
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-33000
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-24000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
27701000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
23149000
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2142000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-918000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
6899000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
6397000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
322000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8530000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
97000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
601000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-251000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1016000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6889000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3663000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7407000
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5400000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-33193000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-18816000
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-8000
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
228000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-132694000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-126789000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1064000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5248000
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
300634000
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
60437000
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
130000000
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
200000000
CY2022 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
975000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-171698000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
134315000
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
24984000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
195315000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
492000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
194832000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
44951000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-109560000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
52477000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
215333000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
162856000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105773000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
215333000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
212000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
4372000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
2082000
CY2022 srrk Number Of Agreements
NumberOfAgreements
2
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in accordance with GAAP requires management to make estimates and judgments that may affect the reported amounts of assets and liabilities and related disclosures of contingent assets and liabilities at the date of the financial statements and the related reporting of revenues and expenses during the reporting period. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk and Off-Balance Sheet Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:10pt;">The Company has </span><span style="font-size:10pt;">no</span><span style="font-size:10pt;"> off-balance sheet risk, such as foreign exchange contracts, option contracts or other foreign-hedging arrangements. The Company follows an investment policy approved by the Board of Directors. Its primary objectives are the preservation of capital and maintenance of liquidity. The Company invests only in fixed income instruments denominated and payable in U.S. dollars including obligations of the U.S. government and its agencies and money market funds registered according to SEC Rule 2a-7 of the Investment Company Act of 1940. All securities must have a readily ascertainable market value</span><span style="font-size:7.5pt;">, </span><span style="font-size:10pt;">must be readily marketable and be U.S. dollar denominated.</span></p>
CY2022Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
0
CY2021Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2500000
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2500000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103275000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
212835000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2498000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2498000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105773000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
215333000
CY2022 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24321000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17456000
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7147000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1510000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
212970000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
884000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
212086000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
40194000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
35000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
40159000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
212100000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
30200000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
23
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
3
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17615000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16855000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10231000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7291000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7384000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9564000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3000000.0
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2600000
CY2022Q4 srrk Accrued External Research And Development Expense
AccruedExternalResearchAndDevelopmentExpense
15178000
CY2021Q4 srrk Accrued External Research And Development Expense
AccruedExternalResearchAndDevelopmentExpense
8428000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6800000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1421000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
833000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
460000
CY2022Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
16326530
CY2022Q2 srrk Proceeds From Issuance Of Stock Gross
ProceedsFromIssuanceOfStockGross
205000000.0
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
195300000
CY2020Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3717948
CY2020Q4 us-gaap Share Price
SharePrice
39.00
CY2020Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2179487
CY2020Q4 srrk Pre Funded Warrant Per Share
PreFundedWarrantPerShare
38.9999
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0001
CY2020Q4 srrk Proceeds From Issuance Of Stock Gross
ProceedsFromIssuanceOfStockGross
230000000.0
CY2020Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
215900000
CY2019Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3450000
CY2019Q3 us-gaap Share Price
SharePrice
15.00
CY2019Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
48300000
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
49362141
CY2022 srrk Number Of Share Based Compensation Plans
NumberOfShareBasedCompensationPlans
4
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27701000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23149000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
2000000.0
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
93505000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.321
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
82403000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
36785000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
25800000
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
27446000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7489000
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
52319000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.068
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.068
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.020
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.009
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.006
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.016
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.075
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.065
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.007
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.015
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.320
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4751000
CY2022Q4 srrk Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
5329000
CY2021Q4 srrk Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
7365000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
2579000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
2844000
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
9035000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
173133000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
132198000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
167275000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
124233000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5858000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
7965000
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
5029000
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
6925000
CY2022Q4 srrk Deferred Tax Liabilities Fixed And Intangible Assets
DeferredTaxLiabilitiesFixedAndIntangibleAssets
829000
CY2021Q4 srrk Deferred Tax Liabilities Fixed And Intangible Assets
DeferredTaxLiabilitiesFixedAndIntangibleAssets
1040000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5858000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7965000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
43000000.0
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
42300000
CY2022 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
101200000
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
27400000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022 us-gaap Sublease Income
SubleaseIncome
2700000
CY2021 us-gaap Sublease Income
SubleaseIncome
2300000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
8675000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
2080000
CY2022 us-gaap Lease Cost
LeaseCost
10755000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
9183000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.075
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
9057000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8051000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4498000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
21606000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1954000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
19652000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7852000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11800000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
8700000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
8600000
CY2022 us-gaap Payments To Suppliers
PaymentsToSuppliers
2900000
CY2022Q4 us-gaap Other Commitment
OtherCommitment
3700000
CY2022 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
3700000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1389000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
16667000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
16667000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
16277000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
51000000
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
4700000
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
2100000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-134502000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-131799000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59611656
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36711833
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.26
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.59
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18369487
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4058301
CY2020Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2020Q1 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2020Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
800000
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
700000
CY2022Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
39
CY2022Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.25
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
1900000
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
100000

Files In Submission

Name View Source Status
0001558370-23-002992-index-headers.html Edgar Link pending
0001558370-23-002992-index.html Edgar Link pending
0001558370-23-002992.txt Edgar Link pending
0001558370-23-002992-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
srrk-20221231.xsd Edgar Link pending
srrk-20221231x10k.htm Edgar Link pending
srrk-20221231x10k006.jpg Edgar Link pending
srrk-20221231x10k007.jpg Edgar Link pending
srrk-20221231x10k008.jpg Edgar Link pending
srrk-20221231x10k009.jpg Edgar Link pending
srrk-20221231x10k010.jpg Edgar Link pending
srrk-20221231x10k011.jpg Edgar Link pending
srrk-20221231x10k012.jpg Edgar Link pending
srrk-20221231x10k013.jpg Edgar Link pending
srrk-20221231x10k014.jpg Edgar Link pending
srrk-20221231x10k015.jpg Edgar Link pending
srrk-20221231x10k016.jpg Edgar Link pending
srrk-20221231x10k017.jpg Edgar Link pending
srrk-20221231x10k018.jpg Edgar Link pending
srrk-20221231x10k019.jpg Edgar Link pending
srrk-20221231xex10d26.htm Edgar Link pending
srrk-20221231xex10d26002.jpg Edgar Link pending
srrk-20221231xex10d26003.jpg Edgar Link pending
srrk-20221231xex10d31.htm Edgar Link pending
srrk-20221231xex10d31005.jpg Edgar Link pending
srrk-20221231xex10d31006.jpg Edgar Link pending
srrk-20221231xex10d7.htm Edgar Link pending
srrk-20221231xex21d1.htm Edgar Link pending
srrk-20221231xex23d1.htm Edgar Link pending
srrk-20221231xex31d1.htm Edgar Link pending
srrk-20221231xex31d2.htm Edgar Link pending
srrk-20221231xex32d1.htm Edgar Link pending
srrk-20221231_def.xml Edgar Link unprocessable
srrk-20221231_lab.xml Edgar Link unprocessable
srrk-20221231_pre.xml Edgar Link unprocessable
srrk-20221231x10k_htm.xml Edgar Link completed
srrk-20221231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable